Tumour necrosis factor alpha (TNF-alpha) synthesis has recently been described in the uterus during the preimplantation phase of pregnancy. The present study was undertaken to determine whether preimplantation embryos are a potential target for TNF-alpha in rats. First, the expression of TNF-alpha receptors by blastocysts was demonstrated by ligand binding assay with human 125I-labelled TNF-alpha and reverse transcription-amplification for the p60 receptor form. The functionality of these receptors was then assessed by incubating blastocysts with 3 nmol mouse TNF-alpha l-1 in vitro and determining their morphology and the number of cells after 24 h. At that concentration, cell proliferation in blastocysts was inhibited by TNF-alpha but this was not accompanied by any change in the morphology of the embryos. Similar results were obtained when lower doses of TNF-alpha (30 and 300 pmol l-1) were tested. The rate of glucose consumption of rat blastocysts exposed to 3 nmol TNF-alpha l-1 was not altered when they were incubated with the cytokine for 4 h, but the rate of glucose incorporation decreased over the same period. Our data indicate that rat blastocysts are responsive to physiological concentration of TNF-alpha and that this cytokine has the potential to influence the preimplantation development of rats.
No takes yet. Share an insight, caveat, or question.
Pampfer et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: